Back to search

Article

EIF2S2 as a Prognostic Marker and Therapeutic Target in Glioblastoma: Insights into its Role and Downstream Mechanisms

2024-10-28

Abstract excerpt

<title>Abstract</title> <p>Glioblastoma (GBM) the most common and most aggressive primary brain tumor has a five-year survival rate of less than 5%. The onset of GBM is very complicated and has always been the focus of researchers. This study analyzed data from 155 GBM and 5 normal tissues from The Cancer Genome Atlas (TCGA), and patients were categorized into high and low EIF2S2 expression groups. The Overall su...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
752511fc-9d6c-57fa-bf9d-72c5b6dd19b2
DOI
10.21203/rs.3.rs-5297353/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
EIF2S2 as a Prognostic Marker and Therapeutic Target in Glioblastoma: Insights into its Role and Downstream MechanismsDOI 10.21203/rs.3.rs-5297353/v1
Select a neighboring publication to make it the new centre.